JNJ vs XTNT · P/E 17, rev $49.37B vs rev $43.9M
Johnson & Johnson (JNJ) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported XTNT revenue for 2026-06-30 was $43.9M. Net income was -$12.5M. XTNT currently screens at market cap $91.0M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the JNJ and XTNT stock pages for the full models.
Not investment advice.